MedTrace Logo

Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder

NCT02970721 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3357

Last updated 2018-05-11

No results posted yet for this study

Summary

The objectives of the proposed project are:

1. To describe the patterns of mood stabilizer, antipsychotic, antidepressant, and anxiolytic prescriptions during pregnancy over a period of 12 years (2002-2014) in women aged 13 to 50 years who are diagnosed with bipolar disorder in Ontario.
2. To identify the factors associated with use of antipsychotics, antidepressants, and antipsychotic-antidepressant polytherapy in pregnant women diagnosed with bipolar disorder.
3. To assess the impact of antipsychotics, antidepressants, and antipsychotic-antidepressant polytherapy on the risk of maternal, neonatal, and labour and delivery outcomes in women with bipolar disorder.
4. To assess the impact of antipsychotics, antidepressants, antipsychotic-antidepressant polytherapy on psychiatric readmission rates during the early postpartum period in women with bipolar disorder.

Conditions

Interventions

DRUG

Antipsychotic

Antipsychotic monotherapy

DRUG

Antidepressant

Antidepressant monotherapy

DRUG

Antipsychotic and Antidepressant

Polytherapy

Sponsors & Collaborators

  • Western University, Canada

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-05-31
Completion
2018-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02970721 on ClinicalTrials.gov